Medical Devices are, according to the World Health Organization (WHO), any instrument, apparatus, implement, machine, appliance, implant, reagent for in vitro use, software, material or other related article, intended for a medical purpose. Register today to discover how Forge can help you buy and sell private shares.
Register to add companies to your watchlist and get access to bids/asks activity, last matched price and trade eligibility details.
Register| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4 |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids | $ Total Asks | # Bids | # Asks | Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
| Neuralink | Healthcare Medical Devices | High | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | +0.00% | +32.32% | $1.34B | Series E | 6/2/2025 | $650MM | $9.65B | $49.09 | -- | |||||
| Auris Health | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $738.23MM | Series D-1 | 11/28/2018 | $220.42MM | $2.13B | $0.21 | Partner Fund Management, Wellington Management, D1 Capital Partners, Senator Investment Group, Mithril Capital Management, Lux Capital, Viking Global Investors | |||||
| Imperative Care | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $898.94MM | Series E-3 | 7/25/2024 | $25MM | $1.66B | $6.87 | Ally Bridge Group, D1 Capital Partners, AMED Ventures, Bain Capital Life Sciences, Rock Springs Capital, Innovatus Capital Partners, Pura Vida Investments, Catalio Capital Management, HealthCor, Montreux Growth Partners, INTAI Technology | |||||
| Science Corporation | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $494.02MM | Series C | 3/5/2026 | $230.05MM | $1.5B | $8.36 | Khosla Ventures, Lightspeed Venture Partners, Y Combinator, In-Q-Tel, Quiet Capital, Mangusta Capital, Octant Ventures, RRE Ventures | |||||
| Butterfly Network | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $370.76MM | Series D | 9/27/2018 | $250MM | $1.28B | $10.27 | Bill & Melinda Gates Foundation, Fidelity Investments, Fosun Pharma, Jamaie Dinan | |||||
| Visby Medical | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $412.97MM | Series E | 3/1/2022 | $108.62MM | $1.16B | $32.24 | Ping An Voyager Partners, Healthcare of Ontario Pension Plan, John Doerr, Cedars Sinai Medical Center, ND Capital, Artiman Ventures, Pitango Venture Capital, Blue Water Life Science Advisors, Nissim Capital | |||||
| RapidSOS | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $453.18MM | Series D | 11/19/2025 | $93.94MM | $1.03B | $1.74 | Apax Partners | |||||
| AliveCor | Healthcare Medical Devices | Low | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $277.15MM | Series F | 8/16/2022 | $150MM | $943.68MM | $14.72 | GE Healthcare, NGK-NTK, Khosla Ventures, Bold Capital Partners, Qualcomm Ventures, WP Global Partners | |||||
| RefleXion Medical | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $505.72MM | Series F | 11/15/2023 | $106.71MM | $874.99MM | $1.50 | The Rise Fund, Pictet, Square Point Capital, Ally Bridge Group, Pfizer, Johnson & Johnson, T. Rowe Price, Venrock, Catalio Capital Management, Hillenbrand Capital Partners | |||||
| PROCEPT BioRobotics | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $341.8MM | Series G | 6/30/2021 | $85MM | $872.62MM | $4.02 | Fidelity, T. Rowe Price Associates, CPMG, Perceptive Advisors, Viking Global Investors LP, Duquesne Family Office | |||||
| Synchron | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $318.41MM | Series D | 11/6/2025 | $200MM | $821.5MM | $36.70 | Double Point Ventures, ARCH Venture Partners, Khosla Ventures, Bezos Expeditions, NeuroTechnology Investors, METIS, National Reconstruction Fund Corporation, T.Rx Capital, QIA, K5 Global, Protocol Labs, IQT | |||||
| Mercator MedSystems | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $68.55MM | Series 1 | 3/4/2021 | $58.37MM | $694.21MM | $20.00 | Undisclosed Investors | |||||
| Calyxo | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $155.79MM | Series F | 3/26/2026 | $40.1MM | $658.2MM | $8.82 | Undisclosed Investors | |||||
| HistoSonics | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $308.72MM | Series D-1 | 8/15/2024 | $102.7MM | $598.27MM | $1.60 | Alpha Wave Ventures, Amzak Health, HealthQuest Capital, Johnson & Johnson Innovation, Venture Investors, Lumira Ventures, Yonjin Venture, State of Wisconsin Investment Board | |||||
| Medrobotics | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $197.87MM | Series H | 1/26/2017 | $24.2MM | $585.16MM | $4.84 | Undisclosed Investors | |||||
| Noah Medical | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $548.22MM | Series B-2 | 9/24/2025 | $111.93MM | $571.52MM | $4.31 | Undisclosed Investors | |||||
| Cue Health | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $179.56MM | Series C-1 | 6/10/2020 | $100MM | $455.86MM | $3.66 | Decheng Capital, Foresite Capital, Madrone Capital Partners, Johnson & Johnson Innovation, ACME Capital | |||||
| VitalConnect | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $308.06MM | Series G-1 | 2/19/2025 | $33.85MM | $451.12MM | $0.42 | Ally Bridge Group, EW Healthcare Partners, MVM Life Sciences, Revelation Partners | |||||
| EndoGastric Solutions | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $377.99MM | Series J | 11/25/2020 | $27MM | $448.42MM | $2.51 | Vertex Growth Fund | |||||
| Supira Medical | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $241.09MM | Series E | 3/26/2025 | $120MM | $431.99MM | $1.35 | Novo Holdings, Qatar Investment Authority, Cormorant Asset Management, TCP, 415 Capital, AMED Ventures, Picard Angst, Unorthodox Ventures | |||||
| LightForce | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $150.18MM | Series D | 8/2/2023 | $80MM | $403.11MM | $18.01 | Ally Bridge Group, Transformation Capital, CareCapital, Omega Venture Partners, Matter Venture Partners, American Association of Orthodontics, Kleinger Perkins, Tyche Partners, Matrix Partners | |||||
| Truvian | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $204.13MM | Series D-1 Convertible | 7/17/2024 | $46.73MM | $396.91MM | $0.07 | Wittington Ventures, GreatPoint Ventures, DNS Capital, Medical Excellence Capital, Tao Capital, TYH Ventures, 7wireVentures | |||||
| Svelte Medical Systems | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $153.65MM | Series C | 4/23/2021 | $11.89MM | $396.2MM | $321.83 | Undisclosed Investors | |||||
| Nalu | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $331.77MM | Series E | 10/9/2024 | $115.06MM | $382.56MM | $4.85 | Novo Holdings, Gilde Healthcare, MVM Partners, Endeavour Vision, Decheng Capital, Longitude Capital, Advent Life Sciences, Pura Vida, Aperture Venture Partners, B Capital | |||||
PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES
Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
Post-Money Valuation (valuation) represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions.
Sector and subsector descriptions focus primarily on the types of companies within the respective sectors and subsectors that are typically available through Forge Markets. Any sector or subsector as a whole may include companies that participate in business lines in other sectors or subsectors. Companies are classified into sectors and subsectors according to the problem(s) they seek to solve rather than the method by which the solution is delivered.